Can TV be genuinely supportive for someone living with dementia?
On April 23, Allyson Schrier joins us to share how research following her experience caring for her husband with dementia led her to create Zinnia TV, a streaming service designed to engage people living with memory loss.
Register ↘️
Graphic for an event titled "Understanding Glaucoma’s Disproportionate Impact on Black & Hispanic Communities." It is part of "Glaucoma Chats," presented by the BrightFocus Foundation and the American Glaucoma Society. The event is scheduled for Wednesday, April 8 at 1 pm Eastern. The flyer features a photo of Victoria L. Tseng, MD, PhD, who is an Assistant Professor in Residence at the UCLA Department of Ophthalmology.
Glaucoma doesn’t impact all communities equally. Dr. Victoria Tseng joins us live today, April 8 at 1pm ET, to discuss the latest research on glaucoma disparities, cultural and healthcare barriers, and the importance of early screening to help protect vision.
Listen now: BrightFocus.org/livechatNGR
📸: A 3D rendering of a retinal ganglion cell—the neurons that carry visual signals from your eye to your brain. Dr. Rob Nickells, a BrightFocus Foundation National Glaucoma Research grant recipient, is studying how to protect these cells from glaucoma. https://bit.ly/4tGjBHK
A person holds a pill in their open hand. The text on the image reads: "New Oral Alzheimer’s Therapy Shows Therapeutic Benefit, Time Saved."
Scientists are developing a new pill-based Alzheimer’s treatment that targets a different pathway than the medications already on the market.
Read about this and more top Alzheimer's headlines in our Breaking News Dispatch, supported by sponsorship funding from Lilly: https://bit.ly/41c8HfG
Join us today as Dr. Michael Detke shares details about the SPRING trial studying an investigational oral drug aimed at reducing brain damage linked to the gum‑disease bacteria P. gingivalis.
We'll also outline who may qualify & what participation looks like.
youtube.com/live/y2o7wtfOSX8
In recognition of National Minority Health Month, Dr. Victoria Tseng joins Glaucoma Chats on April 8 to discuss the latest research on glaucoma disparities, cultural and healthcare barriers, and why early screening is critical to protecting vision.
Register to ask your questions live. ↘️
Colorful illustration of a silhouette with a brain outline against a vibrant background. "Breaking News Dispatch: Alzheimer’s Oral Therapies, Prevention Strategies, and Targeted Treatments Emerge."
#BreakingNews from #ADPD2026: New treatment approaches to address unmet needs for people living with Alzheimer’s.
Read about promising data on a pill-based treatment, risk-reducing lifestyle changes effective a decade later, and other top stories: https://bit.ly/4bRwFSi
Join today’s episode of Zoom In on Dementia & Alzheimer’s to explore the early #Alzheimers symptoms to watch for, other medical issues that may look like dementia, and why early conversations with your doctor matter.
Watch live at 1 p.m. today: https://www.youtube.com/live/LF1arJTrzes
Top questions from people living with macular degeneration will be answered live today at 1 p.m. ET!
Join BrightFocus Foundation's #MacularChat for a real-time Q&A with ophthalmologist Dr. Joshua Dunaief.
🔗 Listen live now: BrightFocus.org/livechatMDR
We're hosting an interactive Macular Chat on March 25 where we'll answer your top questions about age-related macular degeneration (AMD).
We’ll cover everything from the different types of AMD to nutrition, supplements, daily living tips, and treatment options.
Register now: https://bit.ly/4rxnNHr
Myelinated axons in the hippocampus-1 by Rubio Atonal, Luis Fernando Image of the hippocampus, a part of the brain critical to learning and memory and affected by Alzheimer’s disease. The blue colour highlights the myelin on individual axons and axonal tracts or bundles. In the brain, each neuronal cell has an axon. The axon is responsible for carrying messages from a neuron to the next cell. Myelin is a coat that insulates those axons, allowing neurons to maintain the speed of message conduction across large distances. In Alzheimer’s disease, the myelin coat is lost. Our research aims to develop strategies to promote, repair and maintain the axonal myelination process.
Look inside the hippocampus: where memories are made! The blue shows myelin, a protective coating on brain "wires" (axons) that speeds up messages between neurons. Dr. Isabelle Aubert is developing a therapy using noninvasive ultrasound waves that may boost myelin production. https://bit.ly/4rkP9Bk
Join Dr. Inas Aboobakar of Mass. Eye and Ear today, March 11 at 1pm ET, as she explains the role of genetics and family history in glaucoma as well as what and when to share with relatives, and how to encourage glaucoma eye exams.
🎧 Listen live: https://bit.ly/4nz3KGw
Join Dr. Inas Aboobakar of Mass. Eye and Ear today, March 11 at 1pm ET, as she explains the role of genetics and family history in glaucoma as well as what and when to share with relatives, and how to encourage glaucoma eye exams.
🎧 Listen live: https://bit.ly/4nz3KGw
On March 26, neurologist Dr. Sharon Cohen joins us to walk through the early signs of Alzheimer's, the conditions that can look like dementia but aren't, and how to have a productive conversation with your doctor.
Bring your questions. Register to join live: https://bit.ly/4qhsHsO
In 2025, 182 clinical trials evaluated 138 experimental drugs, reflecting real momentum in how scientists understand the biology, genetics, and biomarkers driving this disease.
Learn how that progress is translating into new ways to treat the disease.
🔴 WATCH LIVE TODAY: https://bit.ly/4aR3j7l
The image is a promotional banner for "Glaucoma Chats," featuring Inas F. Aboobakar, MD. It includes text: "Discussing Glaucoma With Your Family," scheduled for Wednesday, March 11, 1 pm Eastern.
Family history is one of the strongest risk factors for glaucoma.
Dr. Inas Aboobakar joins Glaucoma Chats to explain the role of genetics and family history in glaucoma, what and when to share with relatives, and how to encourage glaucoma eye exams.
Register: https://bit.ly/4u7l1Lh
From disease-modifying therapies and oral pills to non-pharmacological options, the Alzheimer’s treatment pipeline includes a wider range of approaches than ever before.
Read about what’s to come in 2026 and beyond: https://bit.ly/4aMpGcS
Induced neurons derived from an Alzheimer’s Disease patient. Green: Tuj, Red: NeuN.
Check out these stunning brain cells derived from a person with Alzheimer’s disease.
• Green = Young
• Red = Mature
Dr. Josephy Herdy is using these stem cells to study how to stop brain inflammation in Alzheimer’s disease.
Explore the research: https://bit.ly/3OqvJfz
Early-stage AMD often has no symptoms. By the time people notice vision changes, the disease may have already progressed.
That's why Paul, a stand-up comedian living with AMD, recommends comprehensive eye exams for everyone over 40, even if your vision seems fine. https://bit.ly/49L8K7n
🧬 LIVE today at 1 p.m. ET: Dr. Eric M. Reiman joins us to discuss APOE4, genetic testing, and what it means for your Alzheimer's risk. We'll also discuss treatments, potential side effects, and clinical research opportunities. Your questions welcome! ↘️
https://www.youtube.com/live/XDRd-MRpDRY
Could we prevent Alzheimer's before memory loss begins?
Dr. Joshua Grill explains how researchers are exploring early treatment to slow or stop brain changes associated with Alzheimer’s disease in people at higher risk.
Learn more about this promising area of research ➡️ https://bit.ly/4k3QPMP
Did you know? As many as 20 million U.S. adults aged 40 and older are living with some form of AMD.
Age-related macular degeneration (AMD) is a leading cause of vision loss, yet many people don't know they have it until irreversible vision loss occurs.
This #AMDAwarenessMonth, learn about the importance of regular eye exams, symptoms, risk factors & the latest research: https://bit.ly/4tzVDO1
Image with text on a dark blue background. The text states: "FACT: Macular degeneration is the leading cause of vision loss in Americans 65 and older, causing irreversible damage that affects reading, driving, and recognizing faces."
Reading a text message, recognizing a grandchild's face, navigating a familiar route: these ordinary acts rely on central vision. For nearly 20 million Americans, age-related macular degeneration puts all of that at risk.
But early detection offers hope. Learn more: https://bit.ly/4bD2WOG
Breaking News: On Feb 3, Congress passed, and the President signed into law, the Fiscal Year 2026 appropriations bill providing critical federal funding for the NIH, protecting brain and eye research.
Read more. https://bit.ly/46qFBvV
You wouldn't skip your other wellness appointments—so why skip eye exams?
Cynthia reminds us that protecting our vision deserves the same priority we give to other aspects of self-care. Watch her story. ⬇️
Get the facts about glaucoma this #GlaucomaAwarenessMonth: www.stopglaucoma.org
Graphic for a Macular Chat titled: Can Retinal Implants Restore Vision?
TOMORROW: Learn how retinal prostheses are designed to restore vision—not just slow its loss. Join us Wed, Jan 28 at 1 pm ET to explore the PRIMA implant and other breakthrough technologies currently in production.
Watch live: https://bit.ly/4qJtjXX
This is an eye from a frog that was treated with CRISPR. Because CRISPR mutations that cause gene knockdown are random, we can sometimes get mosaicism, where some cells are healthy, and then the cells beside them are mutants. This is an excellent example of mosaicism, where some photoreceptors are healthy (left side), and others are mutants (right side).
CRISPR in action! The healthy cells (left) & disease-modified cells (right) create a 'mosaic' pattern, typical of gene editing.
Dr. Brittany Carr, BrightFocus Foundation Macular Degeneration Research grantee, is using this technique to build more precise disease models. https://bit.ly/3YKpMMC
For decades, Alzheimer's drugs only treated symptoms. That's changed. Two FDA-approved therapies now target amyloid protein in the brain. But what does that mean for people living with the disease?
Watch live: https://www.youtube.com/live/41AMx2fsdHM
Graphic for Zoom In on Dementia & Alzheimer's
Until recently, there were no Alzheimer's drugs that targeted the underlying causes of the disease. Now there are two.
On Jan 22, hear from a leading neurologist about Leqembi and Kisunla—how they work, who's eligible, and what you need to know.
Register: https://bit.ly/4qhsHsO
Glaucoma doesn’t just affect older adults. It can affect anyone at any age.
Hillary explains why everyone, not just individuals with known risk factors, can benefit from regular eye exams to spot the earliest signs of glaucoma and other eye diseases.
Learn more at: www.stopglaucoma.org
